Cargando…
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971063/ https://www.ncbi.nlm.nih.gov/pubmed/36696019 http://dx.doi.org/10.1007/s12185-023-03543-9 |
| _version_ | 1784898029584646144 |
|---|---|
| author | Kanda, Yoshinobu Mori, Takehiko Narita, Atsushi Wolter, Kevin D. Yoshimatsu, Hiroki Nishimura, Kazuma |
| author_facet | Kanda, Yoshinobu Mori, Takehiko Narita, Atsushi Wolter, Kevin D. Yoshimatsu, Hiroki Nishimura, Kazuma |
| author_sort | Kanda, Yoshinobu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9971063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99710632023-03-01 Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series Kanda, Yoshinobu Mori, Takehiko Narita, Atsushi Wolter, Kevin D. Yoshimatsu, Hiroki Nishimura, Kazuma Int J Hematol Correction Springer Nature Singapore 2023-01-25 2023 /pmc/articles/PMC9971063/ /pubmed/36696019 http://dx.doi.org/10.1007/s12185-023-03543-9 Text en © The Authors 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Kanda, Yoshinobu Mori, Takehiko Narita, Atsushi Wolter, Kevin D. Yoshimatsu, Hiroki Nishimura, Kazuma Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title | Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title_full | Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title_fullStr | Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title_full_unstemmed | Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title_short | Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series |
| title_sort | correction: efficacy and safety of equine anti-thymocyte immunoglobulin (eatg) in three japanese patients with moderate to very severe aplastic anemia: a case series |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971063/ https://www.ncbi.nlm.nih.gov/pubmed/36696019 http://dx.doi.org/10.1007/s12185-023-03543-9 |
| work_keys_str_mv | AT kandayoshinobu correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries AT moritakehiko correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries AT naritaatsushi correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries AT wolterkevind correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries AT yoshimatsuhiroki correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries AT nishimurakazuma correctionefficacyandsafetyofequineantithymocyteimmunoglobulineatginthreejapanesepatientswithmoderatetoverysevereaplasticanemiaacaseseries |